vs
Side-by-side financial comparison of CIVISTA BANCSHARES, INC. (CIVB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $47.3M, roughly 1.8× CIVISTA BANCSHARES, INC.). CIVISTA BANCSHARES, INC. runs the higher net margin — 31.7% vs -38.1%, a 69.8% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 11.3%).
Civista Bancshares, Inc. is a US-based bank holding company operating primarily across the Midwest region. It provides a full suite of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial lending products, as well as wealth management solutions, serving retail consumers, small and medium-sized local businesses and community client segments.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
CIVB vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $83.1M |
| Net Profit | $15.0M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 31.7% | -38.1% |
| Revenue YoY | — | 20.2% |
| Net Profit YoY | 47.4% | -27.9% |
| EPS (diluted) | $0.72 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $47.3M | $83.1M | ||
| Q4 25 | $46.3M | $76.4M | ||
| Q3 25 | $44.2M | $83.3M | ||
| Q2 25 | $41.4M | $79.2M | ||
| Q1 25 | $40.6M | $69.2M | ||
| Q4 24 | $40.4M | $68.2M | ||
| Q3 24 | $39.3M | $58.4M | ||
| Q2 24 | $38.1M | $53.4M |
| Q1 26 | $15.0M | $-31.6M | ||
| Q4 25 | — | $-29.8M | ||
| Q3 25 | $12.8M | $-21.4M | ||
| Q2 25 | $11.0M | $-19.6M | ||
| Q1 25 | $10.2M | $-24.7M | ||
| Q4 24 | — | $-18.9M | ||
| Q3 24 | $8.4M | $-21.0M | ||
| Q2 24 | $7.1M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 31.8% | -40.6% | ||
| Q3 25 | 35.4% | -27.8% | ||
| Q2 25 | 31.1% | -28.0% | ||
| Q1 25 | 29.4% | -39.7% | ||
| Q4 24 | 28.2% | -28.9% | ||
| Q3 24 | 25.2% | -38.4% | ||
| Q2 24 | 21.2% | -50.3% |
| Q1 26 | 31.7% | -38.1% | ||
| Q4 25 | — | -39.1% | ||
| Q3 25 | 28.9% | -25.7% | ||
| Q2 25 | 26.6% | -24.7% | ||
| Q1 25 | 25.0% | -35.8% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | 21.3% | -35.9% | ||
| Q2 24 | 18.5% | -48.0% |
| Q1 26 | $0.72 | $-0.56 | ||
| Q4 25 | $0.59 | $-0.54 | ||
| Q3 25 | $0.68 | $-0.38 | ||
| Q2 25 | $0.71 | $-0.35 | ||
| Q1 25 | $0.66 | $-0.45 | ||
| Q4 24 | $0.62 | $-0.34 | ||
| Q3 24 | $0.53 | $-0.40 | ||
| Q2 24 | $0.45 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $553.9M | $347.7M |
| Total Assets | $4.3B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $553.9M | $347.7M | ||
| Q4 25 | $543.5M | $365.9M | ||
| Q3 25 | $499.0M | $380.3M | ||
| Q2 25 | $404.1M | $385.8M | ||
| Q1 25 | $397.4M | $389.2M | ||
| Q4 24 | $388.5M | $402.2M | ||
| Q3 24 | $394.4M | $241.2M | ||
| Q2 24 | $373.8M | $251.8M |
| Q1 26 | $4.3B | $487.1M | ||
| Q4 25 | $4.3B | $508.1M | ||
| Q3 25 | $4.1B | $511.5M | ||
| Q2 25 | $4.2B | $513.1M | ||
| Q1 25 | $4.1B | $519.4M | ||
| Q4 24 | $4.1B | $534.0M | ||
| Q3 24 | $4.1B | $374.1M | ||
| Q2 24 | $4.0B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CIVB
| Net Interest Income | $37.8M | 80% |
| Noninterest Income | $9.4M | 20% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
